Interventional cardiorhythmology was born with the invention of electrical catheter ablation of the common atrioventricular bundle of His as a palliative treatment of supraventricular arrhythmias refractory to medicinal treatment. This method is now used as a curative treatment. In Wolff-Parkinson-White syndrome, all accessory pathways, whatever their location, can be destroyed with a very high success rate (96 p. 100) and very low morbidity and mortality rates. Reentrant nodal tachycardias can also be treated by catheter ablation with, however, a low risk of atrioventricular block which, for the moment, limits its indications. In intractable ventricular tachycardias, its indications will certainly be extended and its efficacy will increase since numerous recent studies have identified a limited, slow-conduction area (arrhythmogenic substrate) as being the real target for ablation. Other sources of energy are also used for the same purposes, including radiofrequency currents with results that are promising but vary according to the type of arrhythmia treated. Thus, interventional cardiorhythmology is progressively replacing surgery.